Vivek Ramaswamy

Vivek Ramaswamy is an American entrepreneur and politician currently running for governor of Ohio. His career has faced various allegations and controversies, though he has not been convicted of any crimes. In 2023, former employees sued Strive Asset Management, claiming Ramaswamy pressured them to violate securities laws, misrepresented company finances, and participated in discriminatory employment practices. His tenure at Roivant Sciences and its subsidiary, Axovant, was marked by allegations of pump-and-dump tactics, particularly regarding the Alzheimer’s drug intepirdine, which failed clinical trials after an IPO generated significant capital for the firm and Ramaswamy personally. Critics have frequently questioned the timing of his profitable stock trades during his prior hedge fund career. Additionally, Ramaswamy faced criticism for hiring a Wikipedia editor to remove references to a Soros-funded fellowship during his 2024 presidential campaign.